Your browser doesn't support javascript.
loading
A phase II evaluation of cediranib in the treatment of recurrent or persistent endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study.
Bender, David; Sill, Michael W; Lankes, Heather A; Reyes, Henry D; Darus, Christopher J; Delmore, James E; Rotmensch, Jacob; Gray, Heidi J; Mannel, Robert S; Schilder, Jeanne M; Hunter, Mark I; McCourt, Carolyn K; Samuelson, Megan I; Leslie, Kimberly K.
Afiliação
  • Bender D; Gynecologic Oncology Division, University of Iowa, Gyn/Onc Division, Iowa City, IA 52242, United States. Electronic address: david-bender@uiowa.edu.
  • Sill MW; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: msill@gogstats.org.
  • Lankes HA; NRG Oncology Statistics & Data Management Center, Roswell Park Cancer Institute, Buffalo, NY 14263, United States. Electronic address: hlankes@gogstats.org.
  • Reyes HD; Gynecologic Oncology Division, University of Iowa, Gyn/Onc Division, Iowa City, IA 52242, United States. Electronic address: henry-reyes@uiowa.edu.
  • Darus CJ; Division of Gynecologic Oncology, Maine Medical Center, Scarborough, ME 04101, United States. Electronic address: cdarus@gmail.com.
  • Delmore JE; University of Kansas School of Medicine, Wichita CCOP, Wichita, KS 67208, United States. Electronic address: james.delmore@awhobgyn.com.
  • Rotmensch J; Division of Gynecologic Oncology, Rush-Presbyterian St. Lukes Medical Center, Chicago, IL 60612, United States. Electronic address: jacob_rotmensch@rush.edu.
  • Gray HJ; Dept. of OB/GYN, University of Washington, Seattle, WA 98195, United States. Electronic address: hgray@u.washington.edu.
  • Mannel RS; Dept. of OB/GYN, The University of Oklahoma Health Sciences Center, Oklahoma City, OK 73104, United States. Electronic address: robert-mannel@ouhsc.edu.
  • Schilder JM; Dept. of Gyn/Onc, Indiana University Medical Center, Indianapolis, IN 46202, United States. Electronic address: jschilde@iupui.edu.
  • Hunter MI; Ellis Fischel Cancer Center, Columbia, MO 65203, United States. Electronic address: hunterm@health.missouri.edu.
  • McCourt CK; Dept. of Oncology, Women & Infants Hospital, Providence, RI 02905, United States. Electronic address: McCourtc@wudosis.wustl.edu.
  • Samuelson MI; Gynecologic Oncology Division, University of Iowa, Gyn/Onc Division, Iowa City, IA 52242, United States.
  • Leslie KK; Gynecologic Oncology Division, University of Iowa, Gyn/Onc Division, Iowa City, IA 52242, United States. Electronic address: Kimberly-leslie@uiowa.edu.
Gynecol Oncol ; 138(3): 507-12, 2015 Sep.
Article em En | MEDLINE | ID: mdl-26186911
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias do Endométrio / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinazolinas / Neoplasias do Endométrio / Inibidores de Proteínas Quinases / Antineoplásicos Tipo de estudo: Guideline Limite: Adult / Aged / Aged80 / Female / Humans / Middle aged Idioma: En Revista: Gynecol Oncol Ano de publicação: 2015 Tipo de documento: Article